These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4866009)

  • 1. Heterologous antilymphocyte sera for immunosuppression in organ transplantation.
    Brendel W; Pichlmayr R; Zenker R
    Ger Med Mon; 1967 Oct; 12(10):495-502. PubMed ID: 4866009
    [No Abstract]   [Full Text] [Related]  

  • 2. Antilymphocyte serum: summary and further observations.
    Woodruff MF
    Transplantation; 1967 Jul; 5(4):Suppl:1127-33. PubMed ID: 4860606
    [No Abstract]   [Full Text] [Related]  

  • 3. Heterologous antilymphocyte sera and some of their effects.
    Russell PS; Monaco AP
    Transplantation; 1967 Jul; 5(4):Suppl:1086-99. PubMed ID: 4860603
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on heterologous antilymphocyte sera and their importance for organ transplantation].
    Pichlmayr R
    Med Klin; 1966 Jun; 61(22):895-6. PubMed ID: 5997062
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship of lymphopenia production and lymphocyte agglutinating and cytotoxic antibody titers to the immunosuppressive potency of heterologous antilymphocyte plasma.
    Jeejeebhoy HF
    Transplantation; 1967 Jul; 5(4):Suppl:1121-6. PubMed ID: 4963509
    [No Abstract]   [Full Text] [Related]  

  • 6. [The immunosuppressive effect of a heterologous dog antilymphocytic serum].
    Pichlmayr R; Brendel W; Pichlmayr I
    Z Gesamte Exp Med Einschl Exp Chir; 1967; 143(3):313-9. PubMed ID: 4969335
    [No Abstract]   [Full Text] [Related]  

  • 7. [Properties of heterologous immune serums against dog lymphocytes].
    Pichlmayr R; Brendel W; Tidow G
    Z Gesamte Exp Med Einschl Exp Chir; 1967; 143(3):299-305. PubMed ID: 5591890
    [No Abstract]   [Full Text] [Related]  

  • 8. The ocular immune response. II. Immune rejection of penetrating corneal homografts. Early versus late treatment with antilymphocyte serum.
    Waltman SR; Burde RM; Faulkner HW
    Transplantation; 1969 Aug; 8(2):147-51. PubMed ID: 4896328
    [No Abstract]   [Full Text] [Related]  

  • 9. Preparation of specific, potent antilymphocyte serum in the horse using dog thymocytes.
    Braf ZF; Smellie WA; Williams GM; Hume DM
    Surg Forum; 1967; 18():227-9. PubMed ID: 4866923
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunosuppressive properties of heterologous antilymphocyte sera (review of the literature)].
    Khundanov LL; Portnoĭ VF; Kipervasser EM; Shatalova IN
    Eksp Khir Anesteziol; 1969; 14(2):41-6. PubMed ID: 4391647
    [No Abstract]   [Full Text] [Related]  

  • 11. [Heterologous antilymphocytic sera in the immune suppression of organ transplantations].
    Brendel W; Pichlmayr R
    Dtsch Med Wochenschr; 1967 Mar; 92(12):549-56. PubMed ID: 5337098
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of heterologous antilymphocyte serum on the immunoreactivity of mice].
    Andreson RK
    Biull Eksp Biol Med; 1970 Mar; 69(3):84-7. PubMed ID: 4928082
    [No Abstract]   [Full Text] [Related]  

  • 13. [Present status of anti-lymphocyte serum and its problems].
    Fujimoto Y
    Geka Chiryo; 1969 Jul; 21(1):86-91. PubMed ID: 4901874
    [No Abstract]   [Full Text] [Related]  

  • 14. Production and effect of heterologous anti-canine lymphocyte serum.
    Pichlmayr R; Brendel W; Zenker R
    Surgery; 1967 May; 61(5):774-83. PubMed ID: 5337424
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of heterologous antilymphocyte and antithymocyte sera in rabbit skin allotransplantation.
    Govallo VI; Kosmiadi GA
    Folia Biol (Praha); 1968; 14(4):293-5. PubMed ID: 4878579
    [No Abstract]   [Full Text] [Related]  

  • 16. Neutrophil function and infection during immunosuppression and transplantation.
    Alexander JW; Hegg ME; McCoy HV; Altemeier WA
    Surg Forum; 1968; 19():198-200. PubMed ID: 4887906
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolonged survival of renal allografts in dogs treated with anti-lymphocyte serum.
    Abbott WM; Otherson HB; Monaco AP; Simmons RL; Russell PS; Wood ML
    Surg Forum; 1966; 17():228-30. PubMed ID: 5331809
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment with heterologous anithymus sera: nephritis associated with modification of renal allograft rejection and the immune status of the host to the foreign protein.
    Guttmann RD; Carpenter CB; Lindquist RR; Merrill JP
    Transplantation; 1967 Jul; 5(4):Suppl:1115-20. PubMed ID: 4860605
    [No Abstract]   [Full Text] [Related]  

  • 19. [The behavior of immunoglobulins and antibody formation during treatment with heterologous antilymphocyte serum].
    Fateh-Moghadam A; Pichlmayr R; Morell C; Knedel M
    Klin Wochenschr; 1967 Jul; 45(13):665-70. PubMed ID: 4172949
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preparation and effect of heterologous anti-dog lymphocyte serums].
    Pichlmayr R
    Z Gesamte Exp Med Einschl Exp Chir; 1967; 143(2):161-226. PubMed ID: 5584706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.